div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader042fdocumentsnetreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page1jpg target=_blank img data-url=documentespanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentsnetreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails1jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader042fdocumentsnetreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page2jpg target=_blank img data-url=documentespanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentsnetreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails2jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader042fdocumentsnetreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page3jpg target=_blank img data-url=documentespanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: Española de Investigación y del Metabolismo...